“Patients are in desperate need of an effective treatment, and we are doing everything we can to help find that treatment,” one scientist explained. “The greatest reward would be to see a safe and effective treatment for people who currently have very few options.”
When heart patients are diagnosed with severe AS, how quickly do they need to undergo TAVR? That was the focus of a new analysis published in Open Heart.
Accessing cardiology data for research or population health initiatives is still quite difficult in Europe. Could this new project help reverse that trend?
TCT 2026 will include a full schedule of late-breaking studies focused on minimally invasive interventions, pharmaceutics, structural heart disease and much more.
A new study of more than 11,000 patients suggests that darkness is necessary for the heart to function at full strength. “Light pollution has emerged as a new risk factor for cardiovascular disease," one researcher explained.
The imaging agent could potentially help doctors characterize a malignancy's aggression and identify lesions with a higher likelihood of invasion or metastasis.
Pelacarsen, an investigational heart drug developed by Novartis, did successfully reduce Lp(a) levels in high-risk heart patients. However, it was unable to reduce the risk of major adverse cardiovascular events among those patients.
A new review led by UCLA researchers examines the utility of commercially available AI tools for screening mammography and evidence surrounding their ability to detect interval cancers.
The European Society of Cardiology announced that approximately 33,800 healthcare professionals from 170 countries participated in its latest annual conference.
Stroke patients should begin their road to recovery as soon as they are medically stable, according to a new ASA/AHA guideline. In fact, starting within the first 48 hours is recommended to maximize the patient’s chance of a full recovery.
